JAGX
Jaguar Health, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.71
−1.45%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$614
- Revenue estimate
- $4.8M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$16
- EPS estimate
- -$52
- Revenue actual
- $1.2M
- Revenue estimate
- $4.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.8%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$52 | -$16 | Beat 69.89% | $1.2M |
| May 26, 2026 | -$149 | -$14 | Beat 90.88% | $3.2M |
| Nov 14, 2025 | -$5.08 | -$6.28 | Miss -23.62% | $3.1M |
| Aug 14, 2025 | -$5.08 | -$10 | Miss -101.97% | $3.0M |
| May 15, 2025 | -$18 | -$17 | Beat 7.22% | $2.2M |
| Apr 1, 2024 | -$1.5K | -$595 | Beat 59.55% | $2.3M |
| Nov 14, 2023 | -$1.23 | -$572 | Miss -46427.64% | $2.8M |
| Aug 14, 2023 | -$1.53 | -$633 | Miss -41241.83% | $2.7M |
| May 15, 2023 | -$6.8K | -$3.6K | Beat 46.68% | $2.0M |
| Nov 14, 2022 | -$5.62 | -$13.6K | Miss -241682.74% | $3.1M |
| Aug 22, 2022 | -$17 | -$13.6K | Miss -82252.67% | $2.9M |
| Mar 11, 2022 | -$6.75 | -$35.1K | Miss -519941.78% | $2.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026